Clinical Trial Update: Quitting Caffeine for Better Glucose Metabolism [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating whether quitting caffeine improves glucose metabolism in adults with type 2 diabetes; study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED